CYTOO solutions can transform conventional cellular models grown as monolayers into a more in vivo like phenotype. Thanks to its know-how on Micropattern technology, CYTOO develops more physiological cellular models, with a higher level of differentiation and maturation, or a 3D organization (spheroids).

CYTOO’s cellular models can be in-licensed should you wish to further develop novel HCA compatible read-outs and assays. Contact us for in-licensing options.

CYTOO offers custom cellular model and cell-based assay development through research contracts. Through our partnerships with the industry and academia, we have also gained expertise in angiogenesis, in working with neural cells (neurite outgrowth…), developed various acini and cyst models, and assisted in micropatterning over 200 different cell types.

We have further developed first-in-class and best-in-class cell-based assays based on our proprietary cellular models:

• human myotube atrophy/hypertrophy assay
• spheroid cancer drug profiling assay

These assays are available for screening as fee-for-service or for in-licensing.

For more information on our cellular models and Cell-Based Assays, please contact us.

A non exhaustive list of advanced cellular models is displayed below: